Home Science Team Press Contact

Press & Publications

Coverage and
published research.

Scientific American, NPR Radiolab, Cell Press, CBC News, and others have covered HelioFlux's biophotonic cancer detection research.

NVIDIA Inception Program Member

Media Coverage

Scientific American

Biophoton research highlighted as potentially groundbreaking

Feature coverage on ultra-weak photon emissions and implications for disease detection.

Read article ↗

NPR Radiolab

The Spark of Life

National audience feature exploring the science behind biophoton signaling.

Listen ↗

CBC News

Canadian researcher's cancer detection breakthrough

Television feature on Dr. Murugan's biophotonic cancer detection work at Wilfrid Laurier University.

Watch ↗

LA Business Journal

HelioFlux featured in Los Angeles startup coverage

Coverage of HelioFlux's approach to non-invasive cancer screening and the LA biotech landscape.

Read article ↗

Peer-Reviewed Publications

Three studies. One trajectory.

92%
In Vitro Validation
30 samples · 6 cancer cell lines · discriminant accuracy
Biochemistry & Biophysics Reports · Elsevier · 2018
Read paper ↗
90%
In Vivo Validation
47 animal models · 13 cancer types · 24-hour detection
Cancers · MDPI · 2020
Read paper ↗
20
Human Subjects
First photoencephalography study · brain activity via light
iScience · Cell Press · 2025
Read paper ↗

For press inquiries, partnership opportunities, or to request our full deck:

Contact Us
© 2026 HelioFlux Inc.Not FDA cleared. Not intended to diagnose or treat any disease.